Pain Killer Soma Needs Controls, Says DEA

WASHINGTON (CN) - Because of the threats of abuse and trafficking of the pain killer carisoprodol, sold as "Soma," the Drug Enforcement Administration plans to place controls on its movement, according to a proposed regulation.

Currently, the drug needs a regular prescription, but, since carisoprodol is being diverted and may be addictive, according to a report by the Food and Drug Administration, the DEA plans to make it a Schedule IV controlled substance.

Processing or moving a substance classified into Schedule IV under the Controlled Substances Act requires registration with the DEA. The drug also must have security and special labeling. It would be a crime to handle carisoprodol and products containing it, without following the controls.

Click the document icon for this and other regulations.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit